Literature DB >> 6094660

A study of Coxsackie B virus infections, 1972-1983.

E J Bell, R A McCartney.   

Abstract

The results of a twelve-year study of Coxsackie B virus (CBV) infections in patients with a variety of acute and chronic illnesses are reported. CBVs were isolated from only 123 patients most of whom were children with respiratory illness. Virus diagnosis in adults was based mainly on the detection of significant rising or static high neutralizing antibody titres. Between 1972 and 1979 most investigations centred on patients with suspected viral heart disease, 12% of whom were found to have diagnostically significant CBV titres. In studies on patients with definite myo-pericarditis the number positive increased to 33%. In 1980 clinical interest switched to the possible role of CBV in myalgic encephalomyelitis (ME), an illness of diverse symptomatology. Investigation of suspected cases of ME in 1983 showed that 16% were serologically positive compared to 4% of normal adults in the West of Scotland. In patients with well-documented ME this figure rose to 41%. The demand by clinicians for CBV neutralizing antibody tests has increased over the past twelve years and continues to escalate annually, especially in patients with chronic relapsing illness.

Entities:  

Mesh:

Year:  1984        PMID: 6094660      PMCID: PMC2129449          DOI: 10.1017/s0022172400064718

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  12 in total

1.  Epidemic myalgic encephalomyelitis.

Authors:  P O Behan
Journal:  Practitioner       Date:  1980-08

2.  Role of Coxsackie B viruses in myocardial infarction.

Authors:  S F Wood; A S Rogen; E J Bell; N R Grist
Journal:  Br Heart J       Date:  1978-05

3.  A six-year study of coxsackievirus B infections in heart disease.

Authors:  N R Grist; E J Bell
Journal:  J Hyg (Lond)       Date:  1974-10

4.  Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type I) diabetes mellitus.

Authors:  M L King; A Shaikh; D Bidwell; A Voller; J E Banatvala
Journal:  Lancet       Date:  1983-06-25       Impact factor: 79.321

5.  Specificity of IgM antibodies in acute human coxsackievirus B infections, analysed by indirect solid phase enzyme immunoassay and immunoblot technique.

Authors:  R Dörries; V ter Meulen
Journal:  J Gen Virol       Date:  1983-01       Impact factor: 3.891

6.  Myalgic encephalomyelitis--report of an epidemic.

Authors:  K G Fegan; P O Behan; E J Bell
Journal:  J R Coll Gen Pract       Date:  1983-06

7.  Coxsackie B virus infections and myocardial infarction. Results from a prospective, epidemiologically controlled study.

Authors:  P D Griffiths; G Hannington; J C Booth
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

8.  Coxsackie B virus infection in coronary care unit patients.

Authors:  D O'Neill; J D McArthur; J A Kennedy; G Clements
Journal:  J Clin Pathol       Date:  1983-06       Impact factor: 3.411

9.  Antibody capture radioimmunoassay (MACRIA) for coxsackievirus B4 and B5-specific IgM.

Authors:  P Morgan-Capner; C McSorley
Journal:  J Hyg (Lond)       Date:  1983-06

10.  Coxsackie B infection in a general medical unit.

Authors:  E J Bell; K G Irvine; A J Gardiner; J C Rodger
Journal:  Scott Med J       Date:  1983-04       Impact factor: 0.729

View more
  12 in total

1.  Myalgic encephalomyelitis--a persistent enteroviral infection?

Authors:  E G Dowsett; A M Ramsay; R A McCartney; E J Bell
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

Review 2.  Enteroviruses as agents of emerging infectious diseases.

Authors:  G Palacios; M S Oberste
Journal:  J Neurovirol       Date:  2005-10       Impact factor: 2.643

3.  Meta-analysis of the association of enteroviruses with human heart disease.

Authors:  C Baboonian; T Treasure
Journal:  Heart       Date:  1997-12       Impact factor: 5.994

4.  Secondary enterovirus infection in the murine model of myocarditis. Pathologic and immunologic aspects.

Authors:  M A Beck; N M Chapman; B M McManus; J C Mullican; S Tracy
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

5.  Coxsackie B viruses and myalgic encephalomyelitis.

Authors:  E J Bell; R A McCartney; M H Riding
Journal:  J R Soc Med       Date:  1988-06       Impact factor: 5.344

6.  Coxsackie B viruses and the post-viral syndrome: a prospective study in general practice.

Authors:  B D Calder; P J Warnock; R A McCartney; E J Bell
Journal:  J R Coll Gen Pract       Date:  1987-01

7.  Epidemic Coxsackie B virus infection in Johannesburg, South Africa.

Authors:  B D Schoub; S Johnson; J M McAnerney; I L Dos Santos; K I Klaassen
Journal:  J Hyg (Lond)       Date:  1985-10

8.  Evidence for a group-specific enteroviral antigen(s) recognized by human T cells.

Authors:  M A Beck; S M Tracy
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

9.  Coxsackie virus infections in rheumatic fever.

Authors:  S R Zaher; A S Kassem; J J Hughes
Journal:  Indian J Pediatr       Date:  1993 Mar-Apr       Impact factor: 1.967

10.  The association between prior infection with five serotypes of Coxsackievirus B and incident type 2 diabetes mellitus in the EPIC-Norfolk study.

Authors:  E Gkrania-Klotsas; C Langenberg; S Tauriainen; S J Sharp; R Luben; N G Forouhi; K T Khaw; H Hyöty; N J Wareham
Journal:  Diabetologia       Date:  2012-01-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.